Effect of Rev on the cytoplasmic localization of intron-containing human immunodeficiency virus type 1 RNA

Virology

Volumn 255, Issue 2, 1999, Pages 237-249

  Favaro, Justin P ^a   Maldarelli, Frank ^b   Arrigo, Salvatore J ^a   Schmidt, Michael G ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

REV PROTEIN; VIRUS PROTEIN; VIRUS RNA;

ARTICLE; CELL FRACTIONATION; CELL NUCLEUS MEMBRANE; CELLULAR DISTRIBUTION; GENETIC TRANSFECTION; HUMAN IMMUNODEFICIENCY VIRUS 1; IN SITU HYBRIDIZATION; INTRON; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 0033558718     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1998.9584     Document Type: Article

References (54)

1. Arrigo S. J., Chen I. S. Rev is necessary for translation but not cytoplasmic accumulation of HIV-1 vif, vpr, and env, vpu 2 RNAs. Genes Dev. 5:1991;808-819.
2. Arya S. K., Guo C., Josephs S. F., Wong S. F. Trans-activator gene of human T-lymphotropic virus type III (HTLV-III). Science. 229:1985;69-73.
3. Bassell G. J., Powers C. M., Taneja K. L., Singer R. H. Single mRNAs visualized by ultrastructural in situ hybridization are principally localized at actin filament intersections in fibroblasts. J. Cell Biol. 126:1994;863-876.
4. Berthold E., Maldarelli F. cis-acting elements in human immunodeficiency virus type 1 RNAs direct viral transcripts to distinct intranuclear locations. J. Virol. 70:1996;4667-4682.
5. Bevec D., Jaksche H., Oft M., Wohl T., Himmelspach M., Pacher A., Schebesta M., Koettnitz K., Dobrovnik M., Csonga R., Lottspeich F., Hauber J. Inhibition of HIV-1 replication in lymphocytes by mutants of the Rev cofactor eIF-5A. Science. 271:1996;1858-1860.
6. Bogerd H. P., Fridell R. A., Madore S., Cullen B. R. Identification of a novel cellular cofactor for the Rev, Rex class of retroviral regulatory proteins. Cell. 82:1995;485-494.
7. Borg K. T., Favaro J. P., Arrigo S. J. Involvement of human immunodeficiency virus type-1 splice sites in the cytoplasmic accumulation of viral RNA. Virology. 236:1997;95-103.
8. Campbell L. H., Borg K. T., Haines J. K., Moon R. T., Schoenberg D. R., Arrigo S. J. Human immunodeficiency virus type 1 Rev is required in vivo for binding of poly(A)-binding protein to Rev-dependent RNAs. J. Virol. 68:1994;5433-5438.
9. Cochrane A. W., Chen C. H., Rosen C. A. Specific interaction of the human immunodeficiency virus Rev protein with a structured region in the env mRNA. Proc. Natl. Acad. Sci. USA. 87:1990;1198-1202.
10. Cochrane A. W., Jones K. S., Beidas S., Dillon P. J., Skalka A. M., Rosen C. A. Identification and characterization of intragenic sequences which repress human immunodeficiency virus structural gene expression. J. Virol. 65:1991;5305-5313.
11. Cochrane A. W., Perkins A., Rosen C. A. Identification of sequences important in the nucleolar localization of human immunodeficiency virus Rev: relevance of nucleolar localization to function. J. Virol. 64:1990;881-885.
12. D'Agostino D. M., Felber B. K., Harrison J. E., Pavlakis G. N. The Rev protein of human immunodeficiency virus type-1 promotes polysomal association and translation of gag, pol and vpu, env messenger RNAs. Mol. Cell. Biol. 12:1992;1375-1386.
13. Daly T. J., Cook K. S., Gray G. S., Maione T. E., Rusche J. R. Specific binding of HIV-1 recombinant Rev protein to the Rev-responsive element in vitro. Nature. 342:1989;816-819.
14. Dayton A. I. The Rev axis of HIV-1 and its associated host cofactors: a viral window onto the workings of eukaryotic posttranscriptional RNA processing. J. Biomed. Sci. 3:1996;69-77.
15. Dreyfuss G., Matunis M. J., Pinol-Roma S., Burd C. G. hnRNP Proteins and the Biogenesis of mRNA. Annu. Rev. Biochem. 62:1993;289-321.
16. Emerman M., Malim M. H. HIV-1 regulatory, accessory genes: keys to unraveling viral and host cell biology. Science. 280:1998;1880-1884.
17. Emerman M., Vazeux R., Peden K. The rev gene product of the human immunodeficiency virus affects envelope-specific RNA localization. Cell. 57:1989;1155-1165.
18. Favaro J. P., Arrigo S. J. Characterization of Rev function using subgenomic and genomic constructs in T and COS cells. Virology. 228:1997;29-38.
19. Favaro J. P., Borg K. T., Arrigo S. A., Schmidt M. G. Effect of Rev on the Intranuclear Localization of HIV-1 Unspliced RNA. Virology. 249:1998;286-296.
20. Feinberg M. B., Jarrett R. F., Aldovini A., Gallo R. C., Wong S. F. HTLV-III expression and production involve complex regulation at the levels of splicing and translation of viral RNA. Cell. 46:1986;807-817.
21. Felber B. K., Hadzopoulou C. M., Cladaras C., Copeland T., Pavlakis G. N. rev protein of human immunodeficiency virus type 1 affects the stability and transport of the viral mRNA. Proc. Natl. Acad. Sci. USA. 86:1989;1495-1499.
22. Fischer U., Huber J., Boelens W. C., Mattaj I. W., Luhrmann R. The HIV-1 Rev activation domain is a nuclear export signal that accesses an export pathway used by specific cellular RNAs. Cell. 82:1995;475-483.
23. Fischer U., Meyer S., Teufel M., Heckel C., Luhrmann R., Rautmann G. Evidence that HIV-1 Rev directly promotes the nuclear export of unspliced RNA. EMBO. J. 13:1994;4105-4112.
24. Fornerod M., Ohno M., Yoshida M., Mattaj I. W. CRM1 is an export receptor for leucine-rich nuclear export signals [see comments]. Cell. 90:1997;1051-1060.
25. Fritz C. C., Zapp M. L., Green M. R. A human nucleoporin-like protein that specifically interacts with HIV Rev. Nature. 376:1995;530-533.
26. Garrett E. D., Cullen B. R. Comparative analysis of Rev function in human immunodeficiency virus type-1 and type-2. J. Virol. 66:1992;4288-4294.
27. Green M. R. Pre-mRNA splicing. Annu. Rev. Genet. 20:1986;671-708.
28. Green M. R. Pre-mRNA processing and mRNA nuclear export. Curr. Opin. Cell Biol. 1:1989;519-525.
29. Hadzopoulou C. M., Felber B. K., Cladaras C., Athanassopoulos A., Tse A., Pavlakis G. N. The rev (trs, art) protein of human immunodeficiency virus type 1 affects viral mRNA and protein expression via a cis-acting sequence in the env region. J. Virol. 63:1989;1265-1274.
30. Hammarskjold M. L., Heimer J., Hammarskjold B., Sangwan I., Albert L., Rekosh D. Regulation of human immunodeficiency virus env expression by the rev gene product. J. Virol. 63:1989;1959-1966.
31. Heaphy S., Dingwall C., Ernberg I., Gait M. J., Green S. M., Karn J., Lowe A. D., Singh M., Skinner M. A. HIV-1 regulator of virion expression (Rev) protein binds to an RNA stem-loop structure located within the Rev response element region. Cell. 60:1990;685-693.
32. Huang Y., Carmichael G. C. Role of polyadenylation in nucleocytoplasmic transport of mRNA. Mol. Cell. Biol. 16:1996;1534-1542.
33. Johannessen A. J., Pryme I. F., Vedeler A. Changes in distribution of actin mRNA in different polysome fractions following stimulation of MPC-11 cells. Mol. Cell. Biochem. 142:1995;107-115.
34. Kimura T., Hashimoto I., Nishikawa M., Fujisawa J. I. A role for Rev in the association of HIV-1 gag mRNA with cytoskeletal beta-actin and viral protein expression. Biochimie (Paris). 78:1996;1075-1080.
35. Lawrence J. B., Cochrane A. W., Johnson C. V., Perkins A., Rosen C. A. The HIV-1 Rev protein: a model system for coupled RNA transport and translation. New Biol. 3:1991;1220-1232.
36. Malim M. H., Bohnlein S., Fenrick R., Le S. Y., Maizel J. V., Cullen B. R. Functional comparison of the Rev trans-activators encoded by different primate immunodeficiency virus species. Proc. Natl. Acad. Sci. USA. 86:1989a;8222-8226.
37. Malim M. H., Bohnlein S., Hauber J., Cullen B. R. Functional dissection of the HIV-1 Rev trans-activator-derivation of a trans-dominant repressor of Rev function. Cell. 58:1989b;205-214.
38. Malim M. H., Cullen B. R. Rev and the fate of pre-mRNA in the nucleus: implications for the regulation of RNA processing in eukaryotes. Mol. Cell. Biol. 13:1993;6180-6189.
39. Malim M. H., Hauber J., Le S. Y., Maizel J. V., Cullen B. R. The HIV-1 rev trans-activator acts through a structured target sequence to activate nuclear export of unspliced viral mRNA. Nature. 338:1989c;254-257.
40. Malim M. H., Tiley L. S., McCarn D. F., Rusche J. R., Hauber J., Cullen B. R. HIV-1 structural gene expression requires binding of the Rev trans-activator to its RNA target sequence. Cell. 60:1990;675-683.
41. Muesing M. A., Smith D. H., Capon D. J. Regulation of mRNA accumulation by a human immunodeficiency virus trans-activator protein. Cell. 48:1987;691-701.
42. Neumann M., Felber B. K., Kleinschmidt A., Froese B., Erfle V., Pavlakis G. N., Brack W. R. Restriction of human immunodeficiency virus type 1 production in a human astrocytoma cell line is associated with a cellular block in Rev function. J. Virol. 69:1995;2159-2167.
43. Olsen H. S., Cochrane A. W., Dillon P. J., Nalin C. M., Rosen C. A. Interaction of the human immunodeficiency virus type 1 Rev protein with a structured region in env mRNA is dependent on multimer formation mediated through a basic stretch of amino acids. Genes Dev. 4:1990a;1357-1364.
44. Olsen H. S., Nelbock P., Cochrane A. W., Rosen C. A. Secondary structure is the major determinant for interaction of HIV rev protein with RNA. Science. 247:1990b;845-848.
45. Padgett R. H., Grabowski P. J., Konsarka M. M., Seiler S., Sharp P. A. Splicing of messenger RNA precursors. Annu. Rev. Biochem. 55:1986;1119-1150.
46. Parish J. H. Principles and Practice of Experiments with Nucleic Acids. 1972;Halsted Press, New York.
47. Perkins A., Cochrane A. W., Ruben S. M., Rosen C. A. Structural and functional characterization of the human immunodeficiency virus rev protein. J. Acquir. Immune Defic. Syndr. 2:1989;256-263.
48. Pinol-Roma S., Dreyfuss G. Transcription-dependent and transcription-independent nuclear transport of hnRNP proteins. Science. 253:1991;312-314.
49. Romanov V. I., Zolotukhin A. S., Aleksandroff N. N., Pinto da Silva P., Felber B. K. Posttranscriptional regulation by Rev protein of human immunodeficiency virus type 1 results in nonrandom nuclear localization of gag mRNA. Virology. 228:1997;360-370.
50. Rosen C. A., Terwilliger E., Dayton A., Sodroski J. G., Haseltine W. A. Intragenic cis-acting art gene-responsive sequences of the human immunodeficiency virus. Proc. Natl. Acad. Sci. USA. 85:1988;2071-2075.
51. Ruhl M., Himmelspach M., Bahr G. M., Hammerschmid F., Jaksche H., Wolff B., Aschauer H., Farrington G. K., Probst H., Bevec D., Hauber J. Eukaryotic initiation factor 5A is a cellular target of the human immunodeficiency virus type 1 Rev activation domain mediating trans-activation. J. Cell Biol. 123:1993;1309-1320.
52. Sodroski J., Goh W. C., Rosen C., Dayton A., Terwilliger E., Haseltine W. A second post-transcriptional trans-activator gene required for HTLV-III replication. Nature. 321:1986;412-417.
53. Wen W., Meinkoth J. L., Tsien R. Y., Taylor S. S. Identification of a signal for rapid export of proteins from the nucleus. Cell. 82:1995;463-473.
54. Zapp M. L., Green M. R. Sequence-specific RNA binding by the HIV-1 Rev protein. Nature. 342:1989;714-716.